array:21 [
  "pii" => "X2013251409033685"
  "issn" => "20132514"
  "doi" => "10.3265/Nefrologia.2009.29.6.5534.en.full"
  "estado" => "S300"
  "fechaPublicacion" => "2009-12-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia (English Version). 2009;29:518-24"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 7571
    "formatos" => array:3 [
      "EPUB" => 319
      "HTML" => 6490
      "PDF" => 762
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699509033688"
      "issn" => "02116995"
      "doi" => "10.3265/Nefrologia.2009.29.6.5534.en.full"
      "estado" => "S300"
      "fechaPublicacion" => "2009-12-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2009;29:518-24"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 56621
        "formatos" => array:3 [
          "EPUB" => 254
          "HTML" => 53179
          "PDF" => 3188
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "titulo" => "Homeostasis del magnesio. Etiopatogenia, clínica y tratamiento de la hipomagnesemia. A propósito de un caso"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "518"
            "paginaFinal" => "524"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Magnesium homeostasis. Etiopathogeny, clinical diagnosis and treatment of hypomagnesaemia. A case study"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Elena Pérez González, F. Santos Rodríguez, E. Coto García"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "Elena"
                "apellidos" => "Pérez González"
              ]
              1 => array:2 [
                "Iniciales" => "F."
                "apellidos" => "Santos Rodríguez"
              ]
              2 => array:2 [
                "Iniciales" => "E."
                "apellidos" => "Coto García"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X2013251409033685"
          "doi" => "10.3265/Nefrologia.2009.29.6.5534.en.full"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409033685?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509033688?idApp=UINPBA000064"
      "url" => "/02116995/0000002900000006/v0_201502091341/X0211699509033688/v0_201502091341/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251409033716"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.2009.29.6.5583.en.full"
    "estado" => "S300"
    "fechaPublicacion" => "2009-12-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2009;29:525-33"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 5093
      "formatos" => array:3 [
        "EPUB" => 245
        "HTML" => 4380
        "PDF" => 468
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Spanish Registry of Renal Patients. Dialysis and renal transplants in Spain. 2006 Report"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "525"
          "paginaFinal" => "533"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Informe 2006 de diálisis y trasplante renal en España"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig1"
          "etiqueta" => "Fig. 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier España"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "44018078_f1_p526.jpg"
              "Alto" => 349
              "Ancho" => 399
              "Tamanyo" => 23087
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => " Registro Español de Enfermos Renales, Eduardo Martín Escobar"
          "autores" => array:2 [
            0 => array:1 [
              "apellidos" => "Registro Español de Enfermos Renales"
            ]
            1 => array:2 [
              "nombre" => "Eduardo"
              "apellidos" => "Martín Escobar"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699509033719"
        "doi" => "10.3265/Nefrologia.2009.29.6.5583.en.full"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509033719?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409033716?idApp=UINPBA000064"
    "url" => "/20132514/0000002900000006/v0_201502091611/X2013251409033716/v0_201502091611/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251409033693"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.2009.29.6.5650.en.full"
    "estado" => "S300"
    "fechaPublicacion" => "2009-12-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2009;29:506-17"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 8118
      "formatos" => array:3 [
        "EPUB" => 247
        "HTML" => 6946
        "PDF" => 925
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "titulo" => "Clinical and microbiological aspects of fungal peritonitis in peritoneal dialysis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "506"
          "paginaFinal" => "517"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Aspectos clínicos y microbiológicos de la peritonitis fúngica en diálisis peritoneal"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Tab.  2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier España"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "43818078_t2_p509.jpg"
              "Alto" => 329
              "Ancho" => 827
              "Tamanyo" => 31513
            ]
          ]
          "descripcion" => array:1 [
            "en" => "Dimorphic yeasts and fungi causing peritonitis in peritoneal dialysis"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Rebeca García Agudo, P. García-Martos"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "Rebeca"
              "apellidos" => "García Agudo"
            ]
            1 => array:2 [
              "Iniciales" => "P."
              "apellidos" => "García-Martos"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699509033696"
        "doi" => "10.3265/Nefrologia.2009.29.6.5650.en.full"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509033696?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409033693?idApp=UINPBA000064"
    "url" => "/20132514/0000002900000006/v0_201502091611/X2013251409033693/v0_201502091611/en/main.assets"
  ]
  "en" => array:15 [
    "idiomaDefecto" => true
    "titulo" => "Magnesium homeostasis. Etiopathogeny, clinical diagnosis and treatment of hypomagnesaemia. A case study"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "518"
        "paginaFinal" => "524"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Elena Pérez González, F. Santos Rodríguez, E. Coto García"
        "autores" => array:3 [
          0 => array:4 [
            "nombre" => "Elena"
            "apellidos" => "Pérez González"
            "email" => array:1 [
              0 => "elena_p_g@terra.es"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:3 [
            "Iniciales" => "F."
            "apellidos" => "Santos Rodr&#237;guez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          2 => array:3 [
            "Iniciales" => "E."
            "apellidos" => "Coto Garc&#237;a"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "affc"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Sección de Nefrología Pediátrica. Servicio de Pediatría, Hospital Universitario Virgen Macarena, Sevilla, Sevilla, España, "
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
          1 => array:3 [
            "entidad" => "Sección de Nefrología Pediátrica. Servicio de pediatría., Hospital Central de Asturias, Asturias, Asturias, España, "
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "affb"
          ]
          2 => array:3 [
            "entidad" => "Laboratorio de Genética Molecular, Hospital Central de Asturias, Asturias, Asturias, España, "
            "etiqueta" => "<span class="elsevierStyleSup">c</span>"
            "identificador" => "affc"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Homeostasis del magnesio&#46; Etiopatogenia&#44; cl&#237;nica y tratamiento de la hipomagnesemia&#46; A prop&#243;sito de un caso"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig1"
        "etiqueta" => "Tab.  1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "43918078_t1_p521.jpg"
            "Alto" => 173
            "Ancho" => 827
            "Tamanyo" => 29175
          ]
        ]
      ]
    ]
    "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">INTRODUCTION</span></p><p class="elsevierStylePara">Magnesium is the fourth most abundant cation in the body and the second most abundant cation in the intracellular compartment&#46; It is essential for the function of many enzymes&#44; including enzymes which are associated with the transfer of phosphate groups&#44; all the reactions which require ATP&#44; all the steps involved in the replication and transcription of DNA&#44; and the translation of mRNA&#46; It is estimated that the total amount of magnesium in the body is 1&#44;000mmol or 22&#46;66g&#59; 99&#37; of this total amount of magnesium is located in the intracellular compartment&#44; 60&#37; in the bones&#44; 20&#37; in the muscles and another 20&#37; in other tissues&#46; The translocation of magnesium from the intracellular to the extracellular compartment occurs slowly over a period of several weeks&#46; Only 1&#37; of the total magnesium in the body is found in the extracellular compartment&#46; 60&#37; of this extracellular total is free or ionized magnesium&#44; 10&#37; is bound to citrate&#44; phosphate&#44; and oxalate salts and other anions&#44; with which it forms compounds&#44; and 30&#37; is bound to proteins&#46; The concentration of magnesium in plasma is maintained within a narrow range of 1&#46;7 to 2&#46;2mg&#47;dl &#40;0&#46;75-0&#46;95mmol&#47;l or 1&#46;5-1&#46;9mEq&#47;l&#41;&#46; The homeostasis of magnesium depends on a balance between its intestinal absorption and renal excretion&#46; Hypomagnesaemia is defined as a plasma concentration of magnesium which is lower than 1&#46;7mg&#47;dl &#40;&#60; 0&#46;75mmol&#47;l or &#60; 1&#46;5mEq&#47;l&#41;&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">PHYSIOLOGY OF MAGNESIUM HOMEOSTASIS</span></p><p class="elsevierStylePara">In an average diet&#44; 360mg &#40;15mmol&#41; of elemental magnesium are ingested&#46; The daily requirement of elemental magnesium is 0&#46;15 to 0&#46;20mmol&#47;kg&#46; Sources which are rich in magnesium include cereals&#44; seeds&#44; walnuts&#44; pulses&#44; chocolate&#44; green vegetables&#44; and certain kinds of meat and seafood&#46; Normally&#44; only 50&#37; of the magnesium in our diet is absorbed in the gastrointestinal tract&#44; primarily in the proximal jejunum and the ileum&#46; About 40mg&#47;day of magnesium are also secreted into the intestine and&#44; only 20mg are reabsorbed in the colon and rectum&#46;</p><p class="elsevierStylePara">The absorption of magnesium occurs in the ileum by means of two processes&#58;</p><p class="elsevierStylePara">The first is an active and saturable process&#44; which is the principal route for the transport of magnesium&#46; It occurs across the TRPM6<span class="elsevierStyleSup">1-3</span> magnesium &#40;transient receptor potential melastatin&#41; channel&#46; A second mechanism&#44; which is passive and non-saturable&#44; occurs via the paracellular route&#46;</p><p class="elsevierStylePara">Magnesium is essential for the transfer&#44; storage and use of energy&#44; and it regulates and catalyzes over 300 enzyme systems&#46; Hypomagnesaemia can therefore lead to various metabolic abnormalities and clinical consequences&#44; which are caused by an imbalance between the gastrointestinal absorption and renal excretion of magnesium&#46; The principal manifestation of hypomagnesaemia is heart arrhythmias&#44; which&#44; unless diagnosed and treated&#44; can be fatal&#46;</p><p class="elsevierStylePara">80&#37; of the magnesium found in plasma&#44; 95&#37; of which is reabsorbed by nephrons&#44; is filtered by the glomeruli&#46; Unlike other ions&#44; the tubular absorption of magnesium occurs primarily in the thick ascending limb of Henle&#191;s loop&#44; and it accounts for 60 to 70&#37; of the total amount which is filtered&#46; The proximal tubule absorbs only 15-25&#37; of the magnesium which is filtered&#59; in turn&#44; the distal tubule absorbs 5-10&#37; of the magnesium which is filtered&#44; but it is regarded as the final control point in the regulation of magnesium&#46;<span class="elsevierStyleSup">1</span> In the thick ascending limb of Henle&#191;s loop magnesium is passively reabsorbed together with calcium via the paracellular pathway&#44; which is composed of tight intercellular bonds&#46; The momentum underlying this reabsorption is the electric gradient generated as a result of the reabsorption of sodium by the co-transporter Na&#43;&#47;K&#43;&#47;2Cl-&#40;NKCC2&#41;&#46; Paracelin-1&#44; also known as claudin-16&#44; which has been identified as the protein which forms these tight intercellular bonds&#46;<span class="elsevierStyleSup">4-6</span></p><p class="elsevierStylePara">In the distal tubule&#44; magnesium is reabsorbed by means of an active mechanism&#44; involving the TRPM6 magnesium channel&#46;<span class="elsevierStyleSup">7</span> The mechanism for transporting magnesium in the basolateral membrane of the cells in the thick ascending limb of Henle&#191;s loop and the distal tubule is unknown&#46; The transport of magnesium across this membrane must be against an electrochemical gradient&#46; Most studies suggest there is a sodium-dependent exchange mechanism&#44; which would be favoured by low concentrations of intracellular sodium generated by the Na&#43;&#47;K&#43;-ATPase pump&#46;<span class="elsevierStyleSup">8</span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">FACTORS WHICH INFLUENCE THE EXCRETION OF MAGNESIUM BY THE KIDNEY</span></p><p class="elsevierStylePara">1&#46; The plasma concentration of magnesium is the principal regulator of magnesium in the kidney&#46; Hypermagnesaemia inhibits the reabsorption of magnesium in the thick ascending limb of Henle&#191;s loop&#44; while hypomagnesaemia stimulates it&#46; The plasma concentration of calcium has a similar effect&#46; Hypermagnesaemia and hypercalcaemia inhibit magnesium reabsorption by activating the calcium sensor-receptor in the cells in the thick ascending limb of Henle&#191;s loop and the distal tubule&#46; When magnesium or calcium activate the receptor&#44; this stimulates the formation of an arachidonic acid derivate&#44; which irreversibly inhibits potassium channels in the thick ascending limb of Henle&#191;s loop&#46; The secretion of potassium has two functions&#58; firstly&#44; it provides potassium for the reabsorption of sodium and chlorine by the cotransporter NKCC2 and&#44; secondly&#44; it intervenes in the production of the electric gradient required for the passive reabsorption of magnesium and calcium&#46;<span class="elsevierStyleSup">9</span> Consequently&#44; the inhibition of potassium channels in the thick ascending limb of Henle&#191;s loop would reduce sodium transport and the passive reabsorption of magnesium and calcium&#46;<span class="elsevierStyleSup">10&#44;11</span></p><p class="elsevierStylePara">2&#46; Extracellular fluid volume also influences magnesium excretion&#46; An increase in volume inhibits magnesium reabsorption in the thick ascending limb of Henle&#191;s loop&#44; probably as a result of an increase in the sodium load&#44; and&#44; consequently&#44; a decrease in the electric gradient&#44; which promotes the paracellular transport of magnesium&#46;</p><p class="elsevierStylePara">3&#46; Changes in the glomerular filtration rate can also affect renal magnesium excretion&#46; When the glomerular filtration rate decreases and&#44; as a result&#44; the amount of magnesium which is filtered&#44; the reabsorption of magnesium is reduced&#46;</p><p class="elsevierStylePara">4&#46; Phosphate depletion lowers the reabsorption of magnesium by an unknown mechanism&#46;</p><p class="elsevierStylePara">5&#46; Chronic metabolic acidosis causes renal loss of magnesium&#44; while chronic metabolic alkalosis has the opposite effect&#46; Chronic metabolic acidosis reduces the expression of the TRPM6 magnesium channel in the distal tubule&#44; decreasing magnesium reabsorption in this part of the glomerulus&#46; Chronic metabolic alkalosis increases the expression of this channel&#44; which has the opposite effect&#46;</p><p class="elsevierStylePara">Several hormones&#44; including 1&#46;25&#40;OH&#41;2 vitamine D&#44; parathormone&#44; calcitonin&#44; glucagon&#44; aldosterone&#44; anti-diuretic hormone&#44; insulin&#44; prostaglandin E2 and catecholamines&#44; stimulate magnesium reabsorption in the thick ascending limb of Henle&#191;s loop and the distal tubule&#46; The mechanism is unknown&#44; but in many cases it is believed to be related to an increase in intracellular cAMP&#46; Furthermore&#44; recent studies show that 1&#46;25&#40;OH&#41;2 vitamin D3 can also produce an increase in the expression of paracelin-1 by activating the PPAR transcription factor and subsequently bonding with the specific PPRE response element in the promotor region of the hPCLN-1 gene&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">CAUSES OF HYPOMAGNESAEMIA</span></p><p class="elsevierStylePara">Hypomagnesaemia can occur as a result of four physiopathological mechanisms&#58;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">A decrease in food intake</span></p><p class="elsevierStylePara">Decreased food intake rarely causes magnesium deficiency&#44; as most foods contain significant quantities of this element and the kidney is able to adapt and store magnesium very efficiently&#46; However&#44; hypomagnesaemia can occur in three patient groups&#58; undernourished patients&#44; alcoholics and patients who are administered total parentheral nutrition for prolonged periods of time&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Redistribution</span></p><p class="elsevierStylePara">The translocation of magnesium from the extracellular to the intracellular environment is a common cause of hypomagnesaemia&#46; This can occur in so-called hungry bone syndrome&#44; in which magnesium is deposited in the bones&#46; This syndrome occurs in patients with hyperparathyroidism after they have undergone a parathyroidectomy or in patients with hyperthyroidism after a thyroidectomy&#46;</p><p class="elsevierStylePara">Hypomagnesaemia can also develop as a result of hyperinsulinaemia during the treatment of diabetic ketoacidosis&#44; in refeeding syndrome or during the intravenous administration of dextrose&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Gastrointestinal loss</span></p><p class="elsevierStylePara">Changes in magnesium absorption in the intestine can occur as a result of diarrhoea due to any cause or as a result of surgical resection of the intestine&#46; Patients with ileostomies can develop hypomagnesaemia because there is a certain degree of magnesium reabsorption in the colon&#46;</p><p class="elsevierStylePara">Hypomagnesaemia with secondary hypocalcaemia &#40;HSH&#41; is the result of an autosomal recessive mutation which is characterized by severe hypomagnesaemia associated with hypocalcaemia&#46; The physiopathology of hypomagnesaemia in this disease is linked to a defect in magnesium reabsorption in the intestine and in the distal tubule&#46; Recently&#44; mutations in the TRPM6 gene&#44; which expresses the TRPM6 magnesium channel&#44; have been identified as the underlying genetic cause&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Renal Loss</span></p><p class="elsevierStylePara">Various hereditary tubular defects are responsible for the urinary loss of magnesium&#46; Gitelman&#191;s syndrome is an autosomal recessive disorder caused by mutations of the SCL12A3 gene&#44; which expresses the NaCl cotransporter &#40;NCCT&#41; in the distal tubule&#46; This syndrome is characterized by hypokalaemia&#44; hypomagnesaemia and hypocalciuria associated with metabolic alkalosis&#46; Hypomagnesaemia is present in the majority of patients with Gitelman&#191;s syndrome and in the past it was assumed to be related to a defect in the NCCT cotransporter&#44; but the exact mechanism was unknown&#46; Recently&#44; some studies suggest that the loss of magnesium could be due to decreased expression of the TRPM6 magnesium channel in the distal tubule&#46;<span class="elsevierStyleSup">12-16</span></p><p class="elsevierStylePara">Out of the five variants of Bartter&#191;s syndrome&#44; only classic or type III Bartter&#191;s syndrome is linked to hypomagnesaemia&#46; This variant of Bartter&#191;s syndrome is caused by mutations in the CLCNKB gene&#44; which expresses the CLC-Kb chlorine channel located in the basolateral membrane of the thick ascending limb of Henle&#191;s loop and the distal tubule&#46; This channel measures the flow of chlorine into interstices&#46; The mechanism underlying hypomagnesaemia in this syndrome is unknown&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">CLINICAL MANIFESTATIONS OF HYPOMAGNESAEMIA</span></p><p class="elsevierStylePara">Most patients with hypomagnesaemia present no symptoms&#46; The symptoms of hypomagnesaemia do not appear until the plasma concentration of magnesium falls to values below 1&#46;2mg&#47;dl&#46; Furthermore&#44; hypomagnesaemia is accompanied by other electrolyte changes&#44; such us hypokalaemia and hypocalcaemia&#44; which make it difficult to distinguish clinical manifestations<span class="elsevierStyleSup">17-20</span> which are specifically related to magnesium deficiency&#46; The clinical manifestations of Gitelman&#191;s syndrome are very heterogenous&#44; the symptoms being as subtle as dizziness or vertigo&#44; muscle weakness&#44; cramps and muscular pain&#44; joint pain&#44; fatigue or tiredness&#46;<span class="elsevierStyleSup">21-25</span>&#46;</p><p class="elsevierStylePara">Hypokalaemia<span class="elsevierStyleSup">20</span> is a common finding in patients with hypomagnesaemia&#44; and occurs in 40-60&#37; of cases&#46; This is partly due to the underlying disease that causes losses of both magnesium and potassium&#44; which is what happens&#44; for example&#44; in patients who take diuretics or have diarrhoea&#46; However&#44; the chief mechanism underlying hypokalaemia caused by hypomagnesaemia is in fact related to the intrinsic biophysical properties of the ROMK1 channels<span class="elsevierStyleSup">26</span> &#44;which mediate potassium secretion in the thick ascending limb of Henle&#191;s loop&#46; ROMK1 channels are internal potassium rectifiers&#44; which means they show greater conductance for the potassium which flows into the cell than for potassium flowing out of the cell&#46; The mechanism underlying this preferential conductance into the cell is the result of the bonding and subsequent blocking of the conductance of potassium out of the cell by intracellular magnesium and polyamines&#46; Areduction in intracellular magnesium as a result of magnesium deficiency would induce a decrease in internal rectification and&#44; consequently&#44; an increase in the conductance of potassium out of the cell&#44; with a corresponding loss of potassium and hypokalaemia&#46;</p><p class="elsevierStylePara">Whatever the case&#44; hypokalaemia induced by hypomagnesaemia is characterized by being refractory to treatment with potassium supplements and can only be resolved by correcting the magnesium deficiency&#46;</p><p class="elsevierStylePara">Hypomagnesaemia can also induce hypocalcaemia&#46; This generally occurs when the hypomagnesaemia is severe &#40;&#60; 1&#46;2mg&#47;dl&#41;&#46; The mechanism is multiple&#46; There is a decrease in the release of parathormone&#46; The details of the mechanism are unknown&#44; but it is thought that magnesium might increase the activity of the alpha subunit of the G protein related to CaSR&#46; Hypomagnesaemia can also cause resistance to the action of parathormone on bone tissue&#46; It seems that magnesium deficiency interferes with the production of cAMP&#44; which is the intracellular mediator for parathormone&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">GENETIC STUDY</span></p><p class="elsevierStylePara">The primary defect in this pathology is a mutation that inactivates the SLC12A3 gene located on chromosome 16&#44; which codes for the thiazide-sensitive Na-Cl transporter of the distal convoluted tubule&#46;<span class="elsevierStyleSup">27-32</span> The intron 9 &#43;1G&#62;T mutation is characteristic of gypsy populations&#46; In the case in question&#44; the analysis was performed on the patient and her siblings&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Case report</span></p><p class="elsevierStylePara">We present the case of a formerly healthy 8-year-old gypsy girl who was referred to the hospital suffering from continuous and diffuse abdominal pain of recent onset associated with vomiting&#44; fever and dysuria &#40;table 1&#41;&#46;</p><p class="elsevierStylePara">The genetic study demonstrated that the patient was homozygotic for the intron 9 &#43;1G&#62;T mutation of the SLC12A3 gene&#46;<span class="elsevierStyleSup">33-39</span></p><p class="elsevierStylePara">A genetic study performed on the family obtained the following results&#58;</p><p class="elsevierStylePara">- Brother 1&#58; homozygote for the mutation&#46;</p><p class="elsevierStylePara">- Sister 2&#58; normal homozygote&#44; non carrier&#46;</p><p class="elsevierStylePara">- Sister 3&#58; heterozygote&#44; carrier of the mutation&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">DIAGNOSIS OF HYPOMAGNESAEMIA</span></p><p class="elsevierStylePara">The simplest way to evaluate magnesium deficiency is to measure the plasma concentration of magnesium&#46;<span class="elsevierStyleSup">40-43</span> With regard to the rest&#44; there are two important points to consider&#46; 30&#37; of magnesium is bound to albumin&#59; therefore hypoalbuminaemia can trigger &#191;pseudohypomagnesaemia&#191;&#46; On the other hand&#44; most of the magnesium in the body is located in the intracellular compartment&#46; Therefore&#44; a person can have normal plasma levels of magnesium and still present an intracellular magnesium deficiency and show signs of hypomagnesaemia&#59;<span class="elsevierStyleSup">44-47</span> this is known as functional magnesium deficiency&#46; Unbound ionized magnesium in plasma is the physiologically active form and&#44; in addition&#44; the form which best reflects intracellular magnesium reserves&#46; Unfortunately&#44; in current clinical practice there is no laboratory assay that can measure plasma concentrations of free magnesium&#46;</p><p class="elsevierStylePara"> A way of evaluating functional magnesium deficiency in patients with normal plasma concentrations of magnesium&#44; but in whom there is reason to suspect a magnesium deficiency&#44; is to measure plasma concentrations of magnesium after magnesium loading&#46; Firstly&#44; baseline magnesium excretion is measured in 24 hours urine&#46; After that an infusion of 7&#46;5g of magnesium sulphate is administered after 8 hours and then magnesium excretion is measured after 24 hours if the patient excretes &#60; 70&#37; of the magnesium load plus their baseline magnesium excretion&#44; this is regarded as functional magnesium deficiency&#46;</p><p class="elsevierStylePara">If the cause is not evident&#44; the distinction between renal and gastrointestinal magnesium loss can be made by measuring the amount of magnesium in a 24 hours urine sample or by calculating the magnesium excretion fraction in a urine sample obtained at random&#46; An EFMg higher than 3&#37; or over 1mmol &#40;24mg&#41; of magnesium in 24 hours urine would indicate renal loss of magnesium&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">TREATMENT OF HYPOMAGNESAEMIA</span></p><p class="elsevierStylePara">In general&#44; patients with hypomagnesaemia must follow a diet which is rich in magnesium and the cause of hypomagnesaemia must be treated&#44; whenever posible&#46;<span class="elsevierStyleSup">48</span></p><p class="elsevierStylePara">If the patient has no symptoms or the hypomagnesaemia is not severe &#40;plasma magnesium level &#62; 1mg&#47;dl&#41;&#44; oral administration is the route of choice&#44; preferably using prolonged-release preparations&#44; such as magnesium chloride or lactate&#46; In cases where there are symptoms or when the concentration of magnesium is &#60; 1mg&#47;dl&#44; intravenous administration is the preferred route&#46; The preparation of choice is magnesium sulphate&#46;</p><p class="elsevierStylePara">The plasma magnesium values must be monitored&#44; looking for signs of toxicity&#44; such as oliguria&#44; impaired consciousness and absence of reflexes&#46; Patients with renal failure should receive 50&#37; of the dose if their serum creatinine level is higher than 2&#46; In cases of toxicity&#44; the antidote is intravenous calcium chloride or gluconate&#46; Patients with hypomagnesaemia induced by diuretics&#44; which for some reason cannot be interrupted&#44; may benefit from the use of amiloride&#44; which can reduce the excretion of magnesium in the distal tubule&#46; Amiloride appears to cause hyperpolarization of the cell membrane&#44; which would encourage the production of the transmembrane potential required for magnesium reabsorption&#46;<br></br></p><p class="elsevierStylePara"><a href="grande&#47;43918078&#95;t1&#95;p521&#46;jpg" class="elsevierStyleCrossRefs"><img src="43918078_t1_p521.jpg"></img></a></p><p class="elsevierStylePara">Table 1&#46; </p>"
    "pdfFichero" => "P-E-S-A439-EN.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:3 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec438057"
          "palabras" => array:1 [
            0 => "Hipopotasemia"
          ]
        ]
        1 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec438059"
          "palabras" => array:1 [
            0 => "S&#237;ndrome de Gitelman"
          ]
        ]
        2 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec438061"
          "palabras" => array:1 [
            0 => "Hipomagnesemia"
          ]
        ]
      ]
      "en" => array:3 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec438058"
          "palabras" => array:1 [
            0 => "Hypokaliemia"
          ]
        ]
        1 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec438060"
          "palabras" => array:1 [
            0 => "Gitelman syndrome"
          ]
        ]
        2 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec438062"
          "palabras" => array:1 [
            0 => "Hypomagnesemia"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:1 [
        "resumen" => "Magnesium is the fourth-most abundant cation in the human body and the second-most abundant intracellular cation after potassium&#46; Magnesium is pivotal in the transfer&#44; storage&#44; and utilization of energy as it regulates and catalyzes more than 300 enzyme systems&#46; Hypomagnesemia may thus result in a variety of metabolic abnormalities and clinical consequences&#46; It results from an imbalance between gastrointestinal absorption and renal excretion of magnesium&#46; The main consequence related directly to hypomagnesemia is cardiovascular arrhythmias secondary to hipokaliemia and if this is not recognized and treated it may be fatal&#46; In this article we review the hypomagnesemic disorders in children with emphasis on the molecular mechanisms responsible for abnormalities in magnesium homeostasis&#44; differential diagnosis and appropriate therapy&#44; and we describe the clinical and biochemical manifestations as well as the genetic defect in a family with Gitelman syndrome&#46;"
      ]
      "es" => array:1 [
        "resumen" => "<p class="elsevierStylePara">El magnesio es el cati&#243;n extracelular m&#225;s abundante en el cuerpo humano y el segundo m&#225;s abundante intracelular despu&#233;s del potasio&#46; Es esencial para la transferencia&#44; almacenamiento y utilizaci&#243;n de la energ&#237;a como regulador y catalizador de m&#225;s de 300 sistemas enzim&#225;ticos&#46; La hipomagnesemia puede producir una variedad de anormalidades metab&#243;licas y consecuencias cl&#237;nicas&#46; Puede resultar del desequilibrio entre la absorci&#243;n intestinal y la excreci&#243;n renal&#46; La principal consecuencia relacionada directamente con la hipomagnesemia son las arritmias cardiovasculares por hipopotasemia secundaria&#44; y si no se reconoce y trata puede ser fatal&#46; En este art&#237;culo revisamos las hipomagnesemias haciendo hincapi&#233; en los mecanismos moleculares responsables de la homeostasis del magnesio&#44; diagn&#243;stico diferencial y tratamiento&#44; a prop&#243;sito de la descripci&#243;n de las manifestaciones cl&#237;nicas y bioqu&#237;micas y el defecto gen&#233;tico en una familia afectada de s&#237;ndrome de Gitelman&#46;</p>"
      ]
    ]
    "multimedia" => array:1 [
      0 => array:7 [
        "identificador" => "fig1"
        "etiqueta" => "Tab.  1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "43918078_t1_p521.jpg"
            "Alto" => 173
            "Ancho" => 827
            "Tamanyo" => 29175
          ]
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliography"
      "seccion" => array:1 [
        0 => array:1 [
          "bibliografiaReferencia" => array:48 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Negri L. Trastornos hereditarios del magnesio revelan nuevas proteínas comprometidas en su transporte renal. Nefrología 2008;28:549-53. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18816215" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Weisinger JR, Bellorin-Font E. Magnesium and phosphorus. Lancet 1998;352:391-6.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/9717944" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Rondón-Berríos H. Nephrology Fellow. Renal-Electrolyte Division. Department of Medicine. University of Pittsburgh Medical Center. Pittsburgh, Pennsylvania, USA. Hypomagnesemia. Anales de la Facultad de Medicina.ISSN1025-5583. V.67n.1Lima ene./mar.2006"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Topf JM, Murray PT. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord 2003;4:195-206.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/12766548" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Efrati E, Arsentiev-Rozenfeld J, Zelikovic I. The human paracellin-1 gene (hPCLN-1): renal epithelial cell-specific expression and regulation. Am J Physiol Renal Physiol 2005;288:F272-F283.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/15353399" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Nijenhuis T, Vallon V, Van der Kemp AW, Loffing J, Hoenderop JG, Bindels RJ. Enhanced passive Ca2 reabsorption and reduced Mg2 channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 2005;115:1651-8.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/15902302" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2 resorption. Science 1999;285:103-6.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/10390358" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib8"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002;31:166-70.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/12032568" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib9"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Wang WH, Lu M, Hebert SC. Cytochrome P-450 metabolites mediate extracellular Ca2 -induced inhibition of apical K channels in the TAL. Am J Physiol 1996;271:C103-C111.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/8760035" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib10"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Quamme GA. Renal magnesium handling: New insights in understanding old problems. Kidney Int 1997;52:1180.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/9350641" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib11"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Xi Q, Hoenderop JG, Bindels RJ. Regulation of magnesium reabsortion in DCT. Pflugers Arch 2008; Oct 24."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib12"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Puchades MJ, et al. Alcalosis metabólica hipopotasémica. A propósito de un síndrome de Gitelman. Nefrología. 2004;24(Supl III):72-5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15219074" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib13"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Molina A, et al. Variabilidad clínica del síndrome de Gitelman. Nefrología 2006;26:504-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17058869" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib14"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Giacomo C, Giuseppe R, et al. Abnormal reabsorption of Na /Cl- by the thiazide-inhibitable transporter of the distal convoluted tubule in Gitelman¿s syndrome. Am J Nephrol 1997;17:103-11.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/9096439" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib15"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Vidal Company A, Ruiz Cano R, Gutiérrez Junquera C, Lillo Lillo M. Variabilidad fenotípica del síndrome de Gitelman. An Esp Pediatr 2000;52:285-8.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/11003911" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib16"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Hvelplund C, Jeppesen EM, Mortensen HB, Christiansen P. Generalized seizures as onset of Gitelman¿s syndrome. Ugeskr Laeger 2009;171:818.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/19265613" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib17"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Nachimuthu S, Balamuthusamy S, Irimpen A, Delafontaine P. Calcific constrictive pericarditis with refractory hypokalemia in a patient with Gitelman¿s syndrome. Am J Med Sci 2009;337:74-6.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/19263512" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib18"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Kasifoglu T, Akalin A, Cansu DU, Korkmaz C, Saudi J. Hypokalemic paralysis due to primary hyperaldosteronism simulating Gitelman¿s syndrome. Kidney Dis Transpl 2009;20:285-7."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib19"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Akinci B, Celik A, Saygili F, Yesil S. A case of Gitelman¿s syndrome presenting with extreme hypokalaemia and paralysis. Exp Clin Endocrinol Diabet 2009;117:69-71. Epub 2008 Jun 3."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib20"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Calò LA, Pagnin E, Ceolotto G, Davis PA, Schiavo S, Papparella I, et al. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter¿s/Gitelman¿s syndromes. J Hypertens 2008;26:938-45.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18398336" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib21"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Aoi N, Nakayama T, Sato N, Kosuge K, Haketa A, Sato M, et al. Case-control study of the role of the Gitelman¿s syndrome gene in essential hypertension. Endocr J 2008;55:305-10. Epub 2008 Mar 25.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18362449" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib22"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Calò LA, Puato M, Schiavo S, Zanardo M, Tirrito C, Pagnin E, et al. Absence of vascular remodelling in a high angiotensin-II state (Bartter¿s and Gitelman¿s syndromes): implications for angiotensin II signalling pathways. Nephrol Dial Transplant 2008;23:2804-9. Epub 2008 Mar 14.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18344243" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib23"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Calò LA, Davis PA, Pagnin E, Schiavo S, Semplicini A, Pessina AC. Linking inflammation and hypertension in humans: studies in Bartter's/Gitelman¿s syndrome patients. J Hum Hypertens 2008;22:223-5. Epub 2007 Nov 29.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18046435" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib24"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Volpe A, Caramaschi P, Thalheimer U, Fava C, Ravagnani V, Bambara LM, et al. Familiar association of Gitelman¿s syndrome and calcium pyrophosphate dihydrate crystal deposition disease-a case report. Rheumatology (Oxford) 2007;46:1506-8.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/17666441" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib25"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Peters M, Konrad M, Seyberth HW. Hereditary hypokalemic saltlosing tubular disorders. Saudi J Kidney Dis Transpl 2003;14:386-97.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/17657111" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib26"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Nichols CG, Ho K, Hebert SC. Mg2 -dependent inward rectification of ROMK1 potassium channels expressed in Xenopus oocytes. J Physiol 1994;476:399-409.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/8057249" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib27"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Muthukrishnan J, Modi KD, Kumar PJ, Jha R, Saudi J. Inherited renal tubular defects with hypokalemia. Kidney Dis Transpl 2009;20:274-7."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib28"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "García Pérez A, Coto E, Santos F, Olea T, Caramelo C. Compound heterocygosis for intron 9 1 g &gt; T and Leu850pro mutations inthe SLC12A3 gene in Gitelman¿s syndrome. Nefrología 2008;28:659-60. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19016647" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib29"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Onem Y, Kucukardali Y, Sahan B, Atasoyu EM, Ipcioolu O, Terekeci H, et al. Analyses of subjects with hypokalemic metabolic alkolosis, Gitelman¿s and Bartter¿s syndrome. Ren Fail 2008;30:691-4."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib30"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Chan CF, Mu SC, Lau BH, Chang CJ, Lin SH. Gitelman¿s syndrome: report of one case. Acta Paediatr Taiwan 2008;49:31-4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18581727" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib31"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Shao L, Liu L, Miao Z, Ren H, Wang W, Lang Y, et al. A novel SLC12A3 splicing mutation skipping of two exons and preliminary screening for alternative splice variants in human kidney.Am J Nephrol 2008;28:900-7. Epub 2008 Jun 26. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18580052" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib32"
              "etiqueta" => "32"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Aoki K, Tajima T, Yabushita Y, Nakamura A, Nezu U, Takahashi M, et al. A novel initial codon mutation of the thiazide-sensitive Na-Cl cotransporter gene in a Japanese patient with Gitelman¿s syndrome. Endocr J 2008;55:557-60. Epub 2008 Jun 3. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18520105" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib33"
              "etiqueta" => "33"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Riveira-Munoz E, Devuyst O, Belge H, Jeck N, Strompf L, Vargas-Poussou R, et al. Evaluating PVALB as a candidate gene for SLC12A3-negative cases of Gitelman¿s syndrome. Nephrol Dial Transplant 2008;23:3120-5. Epub 2008 May 9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18469313" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib34"
              "etiqueta" => "34"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Shao L, Ren H, Wang W, Zhang W, Feng X, Li X, et al. Novel SLC12A3 mutations in Chinese patients with Gitelman¿s syndrome. Nephron Physiol 2008;108:29-36."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib35"
              "etiqueta" => "35"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Aoi N, Nakayama T, Tahira Y, Haketa A, Yabuki M, Sekiyama T, et al. Two novel genotypes of the thiazide-sensitive Na-Cl cotransporter (SLC12A3) gene in patients with Gitelman¿s syndrome. Endocrine 2007;31:149-53 <a href="http://www.ncbi.nlm.nih.gov/pubmed/17873326" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib36"
              "etiqueta" => "36"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Fava C, Montagnana M, Rosberg L, Burri P, Jönsson A, Wanby P, et al. Novel mutations in the SLC12A3 gene causing Gitelman¿s syndrome in Swedes. DNA Seq 2007;18:395-9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17654016" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib37"
              "etiqueta" => "37"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Kaito H, Nozu K, Fu XJ, Kamioka I, Fujita T, Kanda K, et al. Detection of a transcript abnormality in mRNA of the SLC12A3 gene extracted from urinary sediment cells of a patient with Gitelman¿s syndrome. Pediatr Res 2007;61:502-5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17414160" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib38"
              "etiqueta" => "38"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Urbanová M, Reiterová J, Rysavá R, Stekrová J, Merta M. Genetic analysis of Gitelman syndrome patients from the Czech Republic and Slovakia-three novel mutations found. Kidney Blood Press Res 2006;29:360-5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17159356" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bib39"
              "etiqueta" => "39"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Riveira-Munoz E, Chang Q, Bindels RJ, Devuyst O. Gitelman¿s syndrome: towards genotype-phenotype correlations? Pediatr Nephrol 2007;22:326-32. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17061123" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            39 => array:3 [
              "identificador" => "bib40"
              "etiqueta" => "40"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Yasujima M. Clinical significance of thiazide-sensitive Na-Cl cotransporter gene by mutational analysis. Rinsho Byori 2007;55:338-43. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17511264" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            40 => array:3 [
              "identificador" => "bib41"
              "etiqueta" => "41"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Calò LA, Davis PA, Palatini P, Semplicini A, Pessina AC. Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter¿s/Gitelman¿s syndromes and relevance for hypertension. J Hum Hypertens 2007;21:904-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17495949" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            41 => array:3 [
              "identificador" => "bib42"
              "etiqueta" => "42"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Scognamiglio R, Negut C, Calò LA. Aborted sudden cardiac death in two patients with Bartter¿s/Gitelman¿s syndromes. Clin Nephrol 2007;67:193-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17390745" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            42 => array:3 [
              "identificador" => "bib43"
              "etiqueta" => "43"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Takeuchi K. Hypertension and metabolic syndrome/lifestyle diseases. Rinsho Byori 2007;55:452-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17593691" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            43 => array:3 [
              "identificador" => "bib44"
              "etiqueta" => "44"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Ariceta G, Rodríguez-Soriano J. Inherited renal tubulopathies associated with metabolic alkalosis: effects on blood pressure. Semin Nephrol 2006;26:422-33. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17275579" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            44 => array:3 [
              "identificador" => "bib45"
              "etiqueta" => "45"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Rosenthal SM, Feldman BJ, Vargas GA, Gitelman SE. Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction. Pediatr Endocrinol Rev 2006;4 (Supl 1):66-70. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17261972" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            45 => array:3 [
              "identificador" => "bib46"
              "etiqueta" => "46"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Eto K, Onaka U, Tsuchihashi T, Hirano T, Nakayama M, Masutani K, et al. A case of Gitelman¿s syndrome with decreased angiotensin IIforming activity. Hypertens Res 2006;29:545-9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17044667" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            46 => array:3 [
              "identificador" => "bib47"
              "etiqueta" => "47"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Addolorato G, Ancarani F, Leggio L, Abenavoli L, De Lorenzi G, Montalto M, et al. Hypokalemic nephropathy in an adult patient with partial empty sella: a classic Bartter¿s syndrome, a Gitelman¿s syndrome or both? Panminerva Med 2006;48:137-42. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16953151" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            47 => array:3 [
              "identificador" => "bib48"
              "etiqueta" => "48"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Morton A. Eplerenone in the treatment of Gitelman¿s syndrome. Intern Med J 2008;38:377. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18402570" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000002900000006/v0_201502091611/X2013251409033685/v0_201502091611/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35445"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Short Reviews"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002900000006/v0_201502091611/X2013251409033685/v0_201502091611/en/P-E-S-A439-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409033685?idApp=UINPBA000064"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Magnesium homeostasis. Etiopathogeny, clinical diagnosis and treatment of hypomagnesaemia. A case study
Homeostasis del magnesio. Etiopatogenia, clínica y tratamiento de la hipomagnesemia. A propósito de un caso
Elena Pérez Gonzáleza, F.. Santos Rodríguezb, E.. Coto Garcíac
a Sección de Nefrología Pediátrica. Servicio de Pediatría, Hospital Universitario Virgen Macarena, Sevilla, Sevilla, España,
b Sección de Nefrología Pediátrica. Servicio de pediatría., Hospital Central de Asturias, Asturias, Asturias, España,
c Laboratorio de Genética Molecular, Hospital Central de Asturias, Asturias, Asturias, España,
Read
18588
Times
was read the article
3189
Total PDF
15399
Total HTML
Share statistics
 array:21 [
  "pii" => "X2013251409033685"
  "issn" => "20132514"
  "doi" => "10.3265/Nefrologia.2009.29.6.5534.en.full"
  "estado" => "S300"
  "fechaPublicacion" => "2009-12-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia &#40;English Version&#41;. 2009;29:518-24"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 7571
    "formatos" => array:3 [
      "EPUB" => 319
      "HTML" => 6490
      "PDF" => 762
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699509033688"
      "issn" => "02116995"
      "doi" => "10.3265/Nefrologia.2009.29.6.5534.en.full"
      "estado" => "S300"
      "fechaPublicacion" => "2009-12-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2009;29:518-24"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 56621
        "formatos" => array:3 [
          "EPUB" => 254
          "HTML" => 53179
          "PDF" => 3188
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "titulo" => "Homeostasis del magnesio&#46; Etiopatogenia&#44; cl&#237;nica y tratamiento de la hipomagnesemia&#46; A prop&#243;sito de un caso"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "518"
            "paginaFinal" => "524"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Magnesium homeostasis&#46; Etiopathogeny&#44; clinical diagnosis and treatment of hypomagnesaemia&#46; A case study"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Elena P&#233;rez Gonz&#225;lez, F. Santos Rodr&#237;guez, E. Coto Garc&#237;a"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "Elena"
                "apellidos" => "P&#233;rez Gonz&#225;lez"
              ]
              1 => array:2 [
                "Iniciales" => "F."
                "apellidos" => "Santos Rodr&#237;guez"
              ]
              2 => array:2 [
                "Iniciales" => "E."
                "apellidos" => "Coto Garc&#237;a"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X2013251409033685"
          "doi" => "10.3265/Nefrologia.2009.29.6.5534.en.full"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409033685?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509033688?idApp=UINPBA000064"
      "url" => "/02116995/0000002900000006/v0_201502091341/X0211699509033688/v0_201502091341/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251409033716"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.2009.29.6.5583.en.full"
    "estado" => "S300"
    "fechaPublicacion" => "2009-12-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2009;29:525-33"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 5093
      "formatos" => array:3 [
        "EPUB" => 245
        "HTML" => 4380
        "PDF" => 468
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Spanish Registry of Renal Patients&#46; Dialysis and renal transplants in Spain&#46; 2006 Report"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "525"
          "paginaFinal" => "533"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Informe 2006 de di&#225;lisis y trasplante renal en Espa&#241;a"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig1"
          "etiqueta" => "Fig. 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier Espa&#241;a"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "44018078_f1_p526.jpg"
              "Alto" => 349
              "Ancho" => 399
              "Tamanyo" => 23087
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => " Registro Espa&#241;ol de Enfermos Renales, Eduardo Mart&#237;n Escobar"
          "autores" => array:2 [
            0 => array:1 [
              "apellidos" => "Registro Espa&#241;ol de Enfermos Renales"
            ]
            1 => array:2 [
              "nombre" => "Eduardo"
              "apellidos" => "Mart&#237;n Escobar"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699509033719"
        "doi" => "10.3265/Nefrologia.2009.29.6.5583.en.full"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509033719?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409033716?idApp=UINPBA000064"
    "url" => "/20132514/0000002900000006/v0_201502091611/X2013251409033716/v0_201502091611/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251409033693"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.2009.29.6.5650.en.full"
    "estado" => "S300"
    "fechaPublicacion" => "2009-12-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2009;29:506-17"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 8118
      "formatos" => array:3 [
        "EPUB" => 247
        "HTML" => 6946
        "PDF" => 925
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "titulo" => "Clinical and microbiological aspects of fungal peritonitis in peritoneal dialysis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "506"
          "paginaFinal" => "517"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Aspectos cl&#237;nicos y microbiol&#243;gicos de la peritonitis f&#250;ngica en di&#225;lisis peritoneal"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Tab.  2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier Espa&#241;a"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "43818078_t2_p509.jpg"
              "Alto" => 329
              "Ancho" => 827
              "Tamanyo" => 31513
            ]
          ]
          "descripcion" => array:1 [
            "en" => "Dimorphic yeasts and fungi causing peritonitis in peritoneal dialysis"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Rebeca Garc&#237;a Agudo, P. Garc&#237;a-Martos"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "Rebeca"
              "apellidos" => "Garc&#237;a Agudo"
            ]
            1 => array:2 [
              "Iniciales" => "P."
              "apellidos" => "Garc&#237;a-Martos"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699509033696"
        "doi" => "10.3265/Nefrologia.2009.29.6.5650.en.full"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509033696?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409033693?idApp=UINPBA000064"
    "url" => "/20132514/0000002900000006/v0_201502091611/X2013251409033693/v0_201502091611/en/main.assets"
  ]
  "en" => array:15 [
    "idiomaDefecto" => true
    "titulo" => "Magnesium homeostasis&#46; Etiopathogeny&#44; clinical diagnosis and treatment of hypomagnesaemia&#46; A case study"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "518"
        "paginaFinal" => "524"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Elena P&#233;rez Gonz&#225;lez, F. Santos Rodr&#237;guez, E. Coto Garc&#237;a"
        "autores" => array:3 [
          0 => array:4 [
            "nombre" => "Elena"
            "apellidos" => "P&#233;rez Gonz&#225;lez"
            "email" => array:1 [
              0 => "elena&#95;p&#95;g&#64;terra&#46;es"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:3 [
            "Iniciales" => "F."
            "apellidos" => "Santos Rodr&#237;guez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          2 => array:3 [
            "Iniciales" => "E."
            "apellidos" => "Coto Garc&#237;a"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "affc"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Sección de Nefrología Pediátrica. Servicio de Pediatría, Hospital Universitario Virgen Macarena, Sevilla, Sevilla, España, "
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
          1 => array:3 [
            "entidad" => "Sección de Nefrología Pediátrica. Servicio de pediatría., Hospital Central de Asturias, Asturias, Asturias, España, "
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "affb"
          ]
          2 => array:3 [
            "entidad" => "Laboratorio de Genética Molecular, Hospital Central de Asturias, Asturias, Asturias, España, "
            "etiqueta" => "<span class="elsevierStyleSup">c</span>"
            "identificador" => "affc"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Homeostasis del magnesio&#46; Etiopatogenia&#44; cl&#237;nica y tratamiento de la hipomagnesemia&#46; A prop&#243;sito de un caso"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig1"
        "etiqueta" => "Tab.  1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "43918078_t1_p521.jpg"
            "Alto" => 173
            "Ancho" => 827
            "Tamanyo" => 29175
          ]
        ]
      ]
    ]
    "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">INTRODUCTION</span></p><p class="elsevierStylePara">Magnesium is the fourth most abundant cation in the body and the second most abundant cation in the intracellular compartment&#46; It is essential for the function of many enzymes&#44; including enzymes which are associated with the transfer of phosphate groups&#44; all the reactions which require ATP&#44; all the steps involved in the replication and transcription of DNA&#44; and the translation of mRNA&#46; It is estimated that the total amount of magnesium in the body is 1&#44;000mmol or 22&#46;66g&#59; 99&#37; of this total amount of magnesium is located in the intracellular compartment&#44; 60&#37; in the bones&#44; 20&#37; in the muscles and another 20&#37; in other tissues&#46; The translocation of magnesium from the intracellular to the extracellular compartment occurs slowly over a period of several weeks&#46; Only 1&#37; of the total magnesium in the body is found in the extracellular compartment&#46; 60&#37; of this extracellular total is free or ionized magnesium&#44; 10&#37; is bound to citrate&#44; phosphate&#44; and oxalate salts and other anions&#44; with which it forms compounds&#44; and 30&#37; is bound to proteins&#46; The concentration of magnesium in plasma is maintained within a narrow range of 1&#46;7 to 2&#46;2mg&#47;dl &#40;0&#46;75-0&#46;95mmol&#47;l or 1&#46;5-1&#46;9mEq&#47;l&#41;&#46; The homeostasis of magnesium depends on a balance between its intestinal absorption and renal excretion&#46; Hypomagnesaemia is defined as a plasma concentration of magnesium which is lower than 1&#46;7mg&#47;dl &#40;&#60; 0&#46;75mmol&#47;l or &#60; 1&#46;5mEq&#47;l&#41;&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">PHYSIOLOGY OF MAGNESIUM HOMEOSTASIS</span></p><p class="elsevierStylePara">In an average diet&#44; 360mg &#40;15mmol&#41; of elemental magnesium are ingested&#46; The daily requirement of elemental magnesium is 0&#46;15 to 0&#46;20mmol&#47;kg&#46; Sources which are rich in magnesium include cereals&#44; seeds&#44; walnuts&#44; pulses&#44; chocolate&#44; green vegetables&#44; and certain kinds of meat and seafood&#46; Normally&#44; only 50&#37; of the magnesium in our diet is absorbed in the gastrointestinal tract&#44; primarily in the proximal jejunum and the ileum&#46; About 40mg&#47;day of magnesium are also secreted into the intestine and&#44; only 20mg are reabsorbed in the colon and rectum&#46;</p><p class="elsevierStylePara">The absorption of magnesium occurs in the ileum by means of two processes&#58;</p><p class="elsevierStylePara">The first is an active and saturable process&#44; which is the principal route for the transport of magnesium&#46; It occurs across the TRPM6<span class="elsevierStyleSup">1-3</span> magnesium &#40;transient receptor potential melastatin&#41; channel&#46; A second mechanism&#44; which is passive and non-saturable&#44; occurs via the paracellular route&#46;</p><p class="elsevierStylePara">Magnesium is essential for the transfer&#44; storage and use of energy&#44; and it regulates and catalyzes over 300 enzyme systems&#46; Hypomagnesaemia can therefore lead to various metabolic abnormalities and clinical consequences&#44; which are caused by an imbalance between the gastrointestinal absorption and renal excretion of magnesium&#46; The principal manifestation of hypomagnesaemia is heart arrhythmias&#44; which&#44; unless diagnosed and treated&#44; can be fatal&#46;</p><p class="elsevierStylePara">80&#37; of the magnesium found in plasma&#44; 95&#37; of which is reabsorbed by nephrons&#44; is filtered by the glomeruli&#46; Unlike other ions&#44; the tubular absorption of magnesium occurs primarily in the thick ascending limb of Henle&#191;s loop&#44; and it accounts for 60 to 70&#37; of the total amount which is filtered&#46; The proximal tubule absorbs only 15-25&#37; of the magnesium which is filtered&#59; in turn&#44; the distal tubule absorbs 5-10&#37; of the magnesium which is filtered&#44; but it is regarded as the final control point in the regulation of magnesium&#46;<span class="elsevierStyleSup">1</span> In the thick ascending limb of Henle&#191;s loop magnesium is passively reabsorbed together with calcium via the paracellular pathway&#44; which is composed of tight intercellular bonds&#46; The momentum underlying this reabsorption is the electric gradient generated as a result of the reabsorption of sodium by the co-transporter Na&#43;&#47;K&#43;&#47;2Cl-&#40;NKCC2&#41;&#46; Paracelin-1&#44; also known as claudin-16&#44; which has been identified as the protein which forms these tight intercellular bonds&#46;<span class="elsevierStyleSup">4-6</span></p><p class="elsevierStylePara">In the distal tubule&#44; magnesium is reabsorbed by means of an active mechanism&#44; involving the TRPM6 magnesium channel&#46;<span class="elsevierStyleSup">7</span> The mechanism for transporting magnesium in the basolateral membrane of the cells in the thick ascending limb of Henle&#191;s loop and the distal tubule is unknown&#46; The transport of magnesium across this membrane must be against an electrochemical gradient&#46; Most studies suggest there is a sodium-dependent exchange mechanism&#44; which would be favoured by low concentrations of intracellular sodium generated by the Na&#43;&#47;K&#43;-ATPase pump&#46;<span class="elsevierStyleSup">8</span></p><p class="elsevierStylePara"><span class="elsevierStyleBold">FACTORS WHICH INFLUENCE THE EXCRETION OF MAGNESIUM BY THE KIDNEY</span></p><p class="elsevierStylePara">1&#46; The plasma concentration of magnesium is the principal regulator of magnesium in the kidney&#46; Hypermagnesaemia inhibits the reabsorption of magnesium in the thick ascending limb of Henle&#191;s loop&#44; while hypomagnesaemia stimulates it&#46; The plasma concentration of calcium has a similar effect&#46; Hypermagnesaemia and hypercalcaemia inhibit magnesium reabsorption by activating the calcium sensor-receptor in the cells in the thick ascending limb of Henle&#191;s loop and the distal tubule&#46; When magnesium or calcium activate the receptor&#44; this stimulates the formation of an arachidonic acid derivate&#44; which irreversibly inhibits potassium channels in the thick ascending limb of Henle&#191;s loop&#46; The secretion of potassium has two functions&#58; firstly&#44; it provides potassium for the reabsorption of sodium and chlorine by the cotransporter NKCC2 and&#44; secondly&#44; it intervenes in the production of the electric gradient required for the passive reabsorption of magnesium and calcium&#46;<span class="elsevierStyleSup">9</span> Consequently&#44; the inhibition of potassium channels in the thick ascending limb of Henle&#191;s loop would reduce sodium transport and the passive reabsorption of magnesium and calcium&#46;<span class="elsevierStyleSup">10&#44;11</span></p><p class="elsevierStylePara">2&#46; Extracellular fluid volume also influences magnesium excretion&#46; An increase in volume inhibits magnesium reabsorption in the thick ascending limb of Henle&#191;s loop&#44; probably as a result of an increase in the sodium load&#44; and&#44; consequently&#44; a decrease in the electric gradient&#44; which promotes the paracellular transport of magnesium&#46;</p><p class="elsevierStylePara">3&#46; Changes in the glomerular filtration rate can also affect renal magnesium excretion&#46; When the glomerular filtration rate decreases and&#44; as a result&#44; the amount of magnesium which is filtered&#44; the reabsorption of magnesium is reduced&#46;</p><p class="elsevierStylePara">4&#46; Phosphate depletion lowers the reabsorption of magnesium by an unknown mechanism&#46;</p><p class="elsevierStylePara">5&#46; Chronic metabolic acidosis causes renal loss of magnesium&#44; while chronic metabolic alkalosis has the opposite effect&#46; Chronic metabolic acidosis reduces the expression of the TRPM6 magnesium channel in the distal tubule&#44; decreasing magnesium reabsorption in this part of the glomerulus&#46; Chronic metabolic alkalosis increases the expression of this channel&#44; which has the opposite effect&#46;</p><p class="elsevierStylePara">Several hormones&#44; including 1&#46;25&#40;OH&#41;2 vitamine D&#44; parathormone&#44; calcitonin&#44; glucagon&#44; aldosterone&#44; anti-diuretic hormone&#44; insulin&#44; prostaglandin E2 and catecholamines&#44; stimulate magnesium reabsorption in the thick ascending limb of Henle&#191;s loop and the distal tubule&#46; The mechanism is unknown&#44; but in many cases it is believed to be related to an increase in intracellular cAMP&#46; Furthermore&#44; recent studies show that 1&#46;25&#40;OH&#41;2 vitamin D3 can also produce an increase in the expression of paracelin-1 by activating the PPAR transcription factor and subsequently bonding with the specific PPRE response element in the promotor region of the hPCLN-1 gene&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">CAUSES OF HYPOMAGNESAEMIA</span></p><p class="elsevierStylePara">Hypomagnesaemia can occur as a result of four physiopathological mechanisms&#58;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">A decrease in food intake</span></p><p class="elsevierStylePara">Decreased food intake rarely causes magnesium deficiency&#44; as most foods contain significant quantities of this element and the kidney is able to adapt and store magnesium very efficiently&#46; However&#44; hypomagnesaemia can occur in three patient groups&#58; undernourished patients&#44; alcoholics and patients who are administered total parentheral nutrition for prolonged periods of time&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Redistribution</span></p><p class="elsevierStylePara">The translocation of magnesium from the extracellular to the intracellular environment is a common cause of hypomagnesaemia&#46; This can occur in so-called hungry bone syndrome&#44; in which magnesium is deposited in the bones&#46; This syndrome occurs in patients with hyperparathyroidism after they have undergone a parathyroidectomy or in patients with hyperthyroidism after a thyroidectomy&#46;</p><p class="elsevierStylePara">Hypomagnesaemia can also develop as a result of hyperinsulinaemia during the treatment of diabetic ketoacidosis&#44; in refeeding syndrome or during the intravenous administration of dextrose&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Gastrointestinal loss</span></p><p class="elsevierStylePara">Changes in magnesium absorption in the intestine can occur as a result of diarrhoea due to any cause or as a result of surgical resection of the intestine&#46; Patients with ileostomies can develop hypomagnesaemia because there is a certain degree of magnesium reabsorption in the colon&#46;</p><p class="elsevierStylePara">Hypomagnesaemia with secondary hypocalcaemia &#40;HSH&#41; is the result of an autosomal recessive mutation which is characterized by severe hypomagnesaemia associated with hypocalcaemia&#46; The physiopathology of hypomagnesaemia in this disease is linked to a defect in magnesium reabsorption in the intestine and in the distal tubule&#46; Recently&#44; mutations in the TRPM6 gene&#44; which expresses the TRPM6 magnesium channel&#44; have been identified as the underlying genetic cause&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Renal Loss</span></p><p class="elsevierStylePara">Various hereditary tubular defects are responsible for the urinary loss of magnesium&#46; Gitelman&#191;s syndrome is an autosomal recessive disorder caused by mutations of the SCL12A3 gene&#44; which expresses the NaCl cotransporter &#40;NCCT&#41; in the distal tubule&#46; This syndrome is characterized by hypokalaemia&#44; hypomagnesaemia and hypocalciuria associated with metabolic alkalosis&#46; Hypomagnesaemia is present in the majority of patients with Gitelman&#191;s syndrome and in the past it was assumed to be related to a defect in the NCCT cotransporter&#44; but the exact mechanism was unknown&#46; Recently&#44; some studies suggest that the loss of magnesium could be due to decreased expression of the TRPM6 magnesium channel in the distal tubule&#46;<span class="elsevierStyleSup">12-16</span></p><p class="elsevierStylePara">Out of the five variants of Bartter&#191;s syndrome&#44; only classic or type III Bartter&#191;s syndrome is linked to hypomagnesaemia&#46; This variant of Bartter&#191;s syndrome is caused by mutations in the CLCNKB gene&#44; which expresses the CLC-Kb chlorine channel located in the basolateral membrane of the thick ascending limb of Henle&#191;s loop and the distal tubule&#46; This channel measures the flow of chlorine into interstices&#46; The mechanism underlying hypomagnesaemia in this syndrome is unknown&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">CLINICAL MANIFESTATIONS OF HYPOMAGNESAEMIA</span></p><p class="elsevierStylePara">Most patients with hypomagnesaemia present no symptoms&#46; The symptoms of hypomagnesaemia do not appear until the plasma concentration of magnesium falls to values below 1&#46;2mg&#47;dl&#46; Furthermore&#44; hypomagnesaemia is accompanied by other electrolyte changes&#44; such us hypokalaemia and hypocalcaemia&#44; which make it difficult to distinguish clinical manifestations<span class="elsevierStyleSup">17-20</span> which are specifically related to magnesium deficiency&#46; The clinical manifestations of Gitelman&#191;s syndrome are very heterogenous&#44; the symptoms being as subtle as dizziness or vertigo&#44; muscle weakness&#44; cramps and muscular pain&#44; joint pain&#44; fatigue or tiredness&#46;<span class="elsevierStyleSup">21-25</span>&#46;</p><p class="elsevierStylePara">Hypokalaemia<span class="elsevierStyleSup">20</span> is a common finding in patients with hypomagnesaemia&#44; and occurs in 40-60&#37; of cases&#46; This is partly due to the underlying disease that causes losses of both magnesium and potassium&#44; which is what happens&#44; for example&#44; in patients who take diuretics or have diarrhoea&#46; However&#44; the chief mechanism underlying hypokalaemia caused by hypomagnesaemia is in fact related to the intrinsic biophysical properties of the ROMK1 channels<span class="elsevierStyleSup">26</span> &#44;which mediate potassium secretion in the thick ascending limb of Henle&#191;s loop&#46; ROMK1 channels are internal potassium rectifiers&#44; which means they show greater conductance for the potassium which flows into the cell than for potassium flowing out of the cell&#46; The mechanism underlying this preferential conductance into the cell is the result of the bonding and subsequent blocking of the conductance of potassium out of the cell by intracellular magnesium and polyamines&#46; Areduction in intracellular magnesium as a result of magnesium deficiency would induce a decrease in internal rectification and&#44; consequently&#44; an increase in the conductance of potassium out of the cell&#44; with a corresponding loss of potassium and hypokalaemia&#46;</p><p class="elsevierStylePara">Whatever the case&#44; hypokalaemia induced by hypomagnesaemia is characterized by being refractory to treatment with potassium supplements and can only be resolved by correcting the magnesium deficiency&#46;</p><p class="elsevierStylePara">Hypomagnesaemia can also induce hypocalcaemia&#46; This generally occurs when the hypomagnesaemia is severe &#40;&#60; 1&#46;2mg&#47;dl&#41;&#46; The mechanism is multiple&#46; There is a decrease in the release of parathormone&#46; The details of the mechanism are unknown&#44; but it is thought that magnesium might increase the activity of the alpha subunit of the G protein related to CaSR&#46; Hypomagnesaemia can also cause resistance to the action of parathormone on bone tissue&#46; It seems that magnesium deficiency interferes with the production of cAMP&#44; which is the intracellular mediator for parathormone&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">GENETIC STUDY</span></p><p class="elsevierStylePara">The primary defect in this pathology is a mutation that inactivates the SLC12A3 gene located on chromosome 16&#44; which codes for the thiazide-sensitive Na-Cl transporter of the distal convoluted tubule&#46;<span class="elsevierStyleSup">27-32</span> The intron 9 &#43;1G&#62;T mutation is characteristic of gypsy populations&#46; In the case in question&#44; the analysis was performed on the patient and her siblings&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Case report</span></p><p class="elsevierStylePara">We present the case of a formerly healthy 8-year-old gypsy girl who was referred to the hospital suffering from continuous and diffuse abdominal pain of recent onset associated with vomiting&#44; fever and dysuria &#40;table 1&#41;&#46;</p><p class="elsevierStylePara">The genetic study demonstrated that the patient was homozygotic for the intron 9 &#43;1G&#62;T mutation of the SLC12A3 gene&#46;<span class="elsevierStyleSup">33-39</span></p><p class="elsevierStylePara">A genetic study performed on the family obtained the following results&#58;</p><p class="elsevierStylePara">- Brother 1&#58; homozygote for the mutation&#46;</p><p class="elsevierStylePara">- Sister 2&#58; normal homozygote&#44; non carrier&#46;</p><p class="elsevierStylePara">- Sister 3&#58; heterozygote&#44; carrier of the mutation&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">DIAGNOSIS OF HYPOMAGNESAEMIA</span></p><p class="elsevierStylePara">The simplest way to evaluate magnesium deficiency is to measure the plasma concentration of magnesium&#46;<span class="elsevierStyleSup">40-43</span> With regard to the rest&#44; there are two important points to consider&#46; 30&#37; of magnesium is bound to albumin&#59; therefore hypoalbuminaemia can trigger &#191;pseudohypomagnesaemia&#191;&#46; On the other hand&#44; most of the magnesium in the body is located in the intracellular compartment&#46; Therefore&#44; a person can have normal plasma levels of magnesium and still present an intracellular magnesium deficiency and show signs of hypomagnesaemia&#59;<span class="elsevierStyleSup">44-47</span> this is known as functional magnesium deficiency&#46; Unbound ionized magnesium in plasma is the physiologically active form and&#44; in addition&#44; the form which best reflects intracellular magnesium reserves&#46; Unfortunately&#44; in current clinical practice there is no laboratory assay that can measure plasma concentrations of free magnesium&#46;</p><p class="elsevierStylePara"> A way of evaluating functional magnesium deficiency in patients with normal plasma concentrations of magnesium&#44; but in whom there is reason to suspect a magnesium deficiency&#44; is to measure plasma concentrations of magnesium after magnesium loading&#46; Firstly&#44; baseline magnesium excretion is measured in 24 hours urine&#46; After that an infusion of 7&#46;5g of magnesium sulphate is administered after 8 hours and then magnesium excretion is measured after 24 hours if the patient excretes &#60; 70&#37; of the magnesium load plus their baseline magnesium excretion&#44; this is regarded as functional magnesium deficiency&#46;</p><p class="elsevierStylePara">If the cause is not evident&#44; the distinction between renal and gastrointestinal magnesium loss can be made by measuring the amount of magnesium in a 24 hours urine sample or by calculating the magnesium excretion fraction in a urine sample obtained at random&#46; An EFMg higher than 3&#37; or over 1mmol &#40;24mg&#41; of magnesium in 24 hours urine would indicate renal loss of magnesium&#46;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">TREATMENT OF HYPOMAGNESAEMIA</span></p><p class="elsevierStylePara">In general&#44; patients with hypomagnesaemia must follow a diet which is rich in magnesium and the cause of hypomagnesaemia must be treated&#44; whenever posible&#46;<span class="elsevierStyleSup">48</span></p><p class="elsevierStylePara">If the patient has no symptoms or the hypomagnesaemia is not severe &#40;plasma magnesium level &#62; 1mg&#47;dl&#41;&#44; oral administration is the route of choice&#44; preferably using prolonged-release preparations&#44; such as magnesium chloride or lactate&#46; In cases where there are symptoms or when the concentration of magnesium is &#60; 1mg&#47;dl&#44; intravenous administration is the preferred route&#46; The preparation of choice is magnesium sulphate&#46;</p><p class="elsevierStylePara">The plasma magnesium values must be monitored&#44; looking for signs of toxicity&#44; such as oliguria&#44; impaired consciousness and absence of reflexes&#46; Patients with renal failure should receive 50&#37; of the dose if their serum creatinine level is higher than 2&#46; In cases of toxicity&#44; the antidote is intravenous calcium chloride or gluconate&#46; Patients with hypomagnesaemia induced by diuretics&#44; which for some reason cannot be interrupted&#44; may benefit from the use of amiloride&#44; which can reduce the excretion of magnesium in the distal tubule&#46; Amiloride appears to cause hyperpolarization of the cell membrane&#44; which would encourage the production of the transmembrane potential required for magnesium reabsorption&#46;<br></br></p><p class="elsevierStylePara"><a href="grande&#47;43918078&#95;t1&#95;p521&#46;jpg" class="elsevierStyleCrossRefs"><img src="43918078_t1_p521.jpg"></img></a></p><p class="elsevierStylePara">Table 1&#46; </p>"
    "pdfFichero" => "P-E-S-A439-EN.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:3 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec438057"
          "palabras" => array:1 [
            0 => "Hipopotasemia"
          ]
        ]
        1 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec438059"
          "palabras" => array:1 [
            0 => "S&#237;ndrome de Gitelman"
          ]
        ]
        2 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec438061"
          "palabras" => array:1 [
            0 => "Hipomagnesemia"
          ]
        ]
      ]
      "en" => array:3 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec438058"
          "palabras" => array:1 [
            0 => "Hypokaliemia"
          ]
        ]
        1 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec438060"
          "palabras" => array:1 [
            0 => "Gitelman syndrome"
          ]
        ]
        2 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec438062"
          "palabras" => array:1 [
            0 => "Hypomagnesemia"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:1 [
        "resumen" => "Magnesium is the fourth-most abundant cation in the human body and the second-most abundant intracellular cation after potassium&#46; Magnesium is pivotal in the transfer&#44; storage&#44; and utilization of energy as it regulates and catalyzes more than 300 enzyme systems&#46; Hypomagnesemia may thus result in a variety of metabolic abnormalities and clinical consequences&#46; It results from an imbalance between gastrointestinal absorption and renal excretion of magnesium&#46; The main consequence related directly to hypomagnesemia is cardiovascular arrhythmias secondary to hipokaliemia and if this is not recognized and treated it may be fatal&#46; In this article we review the hypomagnesemic disorders in children with emphasis on the molecular mechanisms responsible for abnormalities in magnesium homeostasis&#44; differential diagnosis and appropriate therapy&#44; and we describe the clinical and biochemical manifestations as well as the genetic defect in a family with Gitelman syndrome&#46;"
      ]
      "es" => array:1 [
        "resumen" => "<p class="elsevierStylePara">El magnesio es el cati&#243;n extracelular m&#225;s abundante en el cuerpo humano y el segundo m&#225;s abundante intracelular despu&#233;s del potasio&#46; Es esencial para la transferencia&#44; almacenamiento y utilizaci&#243;n de la energ&#237;a como regulador y catalizador de m&#225;s de 300 sistemas enzim&#225;ticos&#46; La hipomagnesemia puede producir una variedad de anormalidades metab&#243;licas y consecuencias cl&#237;nicas&#46; Puede resultar del desequilibrio entre la absorci&#243;n intestinal y la excreci&#243;n renal&#46; La principal consecuencia relacionada directamente con la hipomagnesemia son las arritmias cardiovasculares por hipopotasemia secundaria&#44; y si no se reconoce y trata puede ser fatal&#46; En este art&#237;culo revisamos las hipomagnesemias haciendo hincapi&#233; en los mecanismos moleculares responsables de la homeostasis del magnesio&#44; diagn&#243;stico diferencial y tratamiento&#44; a prop&#243;sito de la descripci&#243;n de las manifestaciones cl&#237;nicas y bioqu&#237;micas y el defecto gen&#233;tico en una familia afectada de s&#237;ndrome de Gitelman&#46;</p>"
      ]
    ]
    "multimedia" => array:1 [
      0 => array:7 [
        "identificador" => "fig1"
        "etiqueta" => "Tab.  1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "43918078_t1_p521.jpg"
            "Alto" => 173
            "Ancho" => 827
            "Tamanyo" => 29175
          ]
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliography"
      "seccion" => array:1 [
        0 => array:1 [
          "bibliografiaReferencia" => array:48 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Negri L. Trastornos hereditarios del magnesio revelan nuevas proteínas comprometidas en su transporte renal. Nefrología 2008;28:549-53. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18816215" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Weisinger JR, Bellorin-Font E. Magnesium and phosphorus. Lancet 1998;352:391-6.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/9717944" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Rondón-Berríos H. Nephrology Fellow. Renal-Electrolyte Division. Department of Medicine. University of Pittsburgh Medical Center. Pittsburgh, Pennsylvania, USA. Hypomagnesemia. Anales de la Facultad de Medicina.ISSN1025-5583. V.67n.1Lima ene./mar.2006"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Topf JM, Murray PT. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord 2003;4:195-206.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/12766548" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Efrati E, Arsentiev-Rozenfeld J, Zelikovic I. The human paracellin-1 gene (hPCLN-1): renal epithelial cell-specific expression and regulation. Am J Physiol Renal Physiol 2005;288:F272-F283.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/15353399" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Nijenhuis T, Vallon V, Van der Kemp AW, Loffing J, Hoenderop JG, Bindels RJ. Enhanced passive Ca2 reabsorption and reduced Mg2 channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 2005;115:1651-8.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/15902302" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2 resorption. Science 1999;285:103-6.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/10390358" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib8"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002;31:166-70.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/12032568" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib9"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Wang WH, Lu M, Hebert SC. Cytochrome P-450 metabolites mediate extracellular Ca2 -induced inhibition of apical K channels in the TAL. Am J Physiol 1996;271:C103-C111.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/8760035" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib10"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Quamme GA. Renal magnesium handling: New insights in understanding old problems. Kidney Int 1997;52:1180.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/9350641" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib11"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Xi Q, Hoenderop JG, Bindels RJ. Regulation of magnesium reabsortion in DCT. Pflugers Arch 2008; Oct 24."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib12"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Puchades MJ, et al. Alcalosis metabólica hipopotasémica. A propósito de un síndrome de Gitelman. Nefrología. 2004;24(Supl III):72-5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15219074" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib13"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Molina A, et al. Variabilidad clínica del síndrome de Gitelman. Nefrología 2006;26:504-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17058869" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib14"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Giacomo C, Giuseppe R, et al. Abnormal reabsorption of Na /Cl- by the thiazide-inhibitable transporter of the distal convoluted tubule in Gitelman¿s syndrome. Am J Nephrol 1997;17:103-11.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/9096439" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib15"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Vidal Company A, Ruiz Cano R, Gutiérrez Junquera C, Lillo Lillo M. Variabilidad fenotípica del síndrome de Gitelman. An Esp Pediatr 2000;52:285-8.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/11003911" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib16"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Hvelplund C, Jeppesen EM, Mortensen HB, Christiansen P. Generalized seizures as onset of Gitelman¿s syndrome. Ugeskr Laeger 2009;171:818.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/19265613" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib17"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Nachimuthu S, Balamuthusamy S, Irimpen A, Delafontaine P. Calcific constrictive pericarditis with refractory hypokalemia in a patient with Gitelman¿s syndrome. Am J Med Sci 2009;337:74-6.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/19263512" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib18"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Kasifoglu T, Akalin A, Cansu DU, Korkmaz C, Saudi J. Hypokalemic paralysis due to primary hyperaldosteronism simulating Gitelman¿s syndrome. Kidney Dis Transpl 2009;20:285-7."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib19"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Akinci B, Celik A, Saygili F, Yesil S. A case of Gitelman¿s syndrome presenting with extreme hypokalaemia and paralysis. Exp Clin Endocrinol Diabet 2009;117:69-71. Epub 2008 Jun 3."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib20"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Calò LA, Pagnin E, Ceolotto G, Davis PA, Schiavo S, Papparella I, et al. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter¿s/Gitelman¿s syndromes. J Hypertens 2008;26:938-45.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18398336" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib21"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Aoi N, Nakayama T, Sato N, Kosuge K, Haketa A, Sato M, et al. Case-control study of the role of the Gitelman¿s syndrome gene in essential hypertension. Endocr J 2008;55:305-10. Epub 2008 Mar 25.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18362449" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib22"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Calò LA, Puato M, Schiavo S, Zanardo M, Tirrito C, Pagnin E, et al. Absence of vascular remodelling in a high angiotensin-II state (Bartter¿s and Gitelman¿s syndromes): implications for angiotensin II signalling pathways. Nephrol Dial Transplant 2008;23:2804-9. Epub 2008 Mar 14.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18344243" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib23"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Calò LA, Davis PA, Pagnin E, Schiavo S, Semplicini A, Pessina AC. Linking inflammation and hypertension in humans: studies in Bartter's/Gitelman¿s syndrome patients. J Hum Hypertens 2008;22:223-5. Epub 2007 Nov 29.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18046435" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib24"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Volpe A, Caramaschi P, Thalheimer U, Fava C, Ravagnani V, Bambara LM, et al. Familiar association of Gitelman¿s syndrome and calcium pyrophosphate dihydrate crystal deposition disease-a case report. Rheumatology (Oxford) 2007;46:1506-8.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/17666441" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib25"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Peters M, Konrad M, Seyberth HW. Hereditary hypokalemic saltlosing tubular disorders. Saudi J Kidney Dis Transpl 2003;14:386-97.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/17657111" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib26"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Nichols CG, Ho K, Hebert SC. Mg2 -dependent inward rectification of ROMK1 potassium channels expressed in Xenopus oocytes. J Physiol 1994;476:399-409.  <a href="http://www.ncbi.nlm.nih.gov/pubmed/8057249" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib27"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Muthukrishnan J, Modi KD, Kumar PJ, Jha R, Saudi J. Inherited renal tubular defects with hypokalemia. Kidney Dis Transpl 2009;20:274-7."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib28"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "García Pérez A, Coto E, Santos F, Olea T, Caramelo C. Compound heterocygosis for intron 9 1 g &gt; T and Leu850pro mutations inthe SLC12A3 gene in Gitelman¿s syndrome. Nefrología 2008;28:659-60. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19016647" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib29"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Onem Y, Kucukardali Y, Sahan B, Atasoyu EM, Ipcioolu O, Terekeci H, et al. Analyses of subjects with hypokalemic metabolic alkolosis, Gitelman¿s and Bartter¿s syndrome. Ren Fail 2008;30:691-4."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib30"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Chan CF, Mu SC, Lau BH, Chang CJ, Lin SH. Gitelman¿s syndrome: report of one case. Acta Paediatr Taiwan 2008;49:31-4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18581727" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib31"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Shao L, Liu L, Miao Z, Ren H, Wang W, Lang Y, et al. A novel SLC12A3 splicing mutation skipping of two exons and preliminary screening for alternative splice variants in human kidney.Am J Nephrol 2008;28:900-7. Epub 2008 Jun 26. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18580052" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bib32"
              "etiqueta" => "32"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Aoki K, Tajima T, Yabushita Y, Nakamura A, Nezu U, Takahashi M, et al. A novel initial codon mutation of the thiazide-sensitive Na-Cl cotransporter gene in a Japanese patient with Gitelman¿s syndrome. Endocr J 2008;55:557-60. Epub 2008 Jun 3. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18520105" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bib33"
              "etiqueta" => "33"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Riveira-Munoz E, Devuyst O, Belge H, Jeck N, Strompf L, Vargas-Poussou R, et al. Evaluating PVALB as a candidate gene for SLC12A3-negative cases of Gitelman¿s syndrome. Nephrol Dial Transplant 2008;23:3120-5. Epub 2008 May 9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18469313" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bib34"
              "etiqueta" => "34"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Shao L, Ren H, Wang W, Zhang W, Feng X, Li X, et al. Novel SLC12A3 mutations in Chinese patients with Gitelman¿s syndrome. Nephron Physiol 2008;108:29-36."
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bib35"
              "etiqueta" => "35"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Aoi N, Nakayama T, Tahira Y, Haketa A, Yabuki M, Sekiyama T, et al. Two novel genotypes of the thiazide-sensitive Na-Cl cotransporter (SLC12A3) gene in patients with Gitelman¿s syndrome. Endocrine 2007;31:149-53 <a href="http://www.ncbi.nlm.nih.gov/pubmed/17873326" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bib36"
              "etiqueta" => "36"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Fava C, Montagnana M, Rosberg L, Burri P, Jönsson A, Wanby P, et al. Novel mutations in the SLC12A3 gene causing Gitelman¿s syndrome in Swedes. DNA Seq 2007;18:395-9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17654016" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bib37"
              "etiqueta" => "37"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Kaito H, Nozu K, Fu XJ, Kamioka I, Fujita T, Kanda K, et al. Detection of a transcript abnormality in mRNA of the SLC12A3 gene extracted from urinary sediment cells of a patient with Gitelman¿s syndrome. Pediatr Res 2007;61:502-5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17414160" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bib38"
              "etiqueta" => "38"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Urbanová M, Reiterová J, Rysavá R, Stekrová J, Merta M. Genetic analysis of Gitelman syndrome patients from the Czech Republic and Slovakia-three novel mutations found. Kidney Blood Press Res 2006;29:360-5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17159356" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bib39"
              "etiqueta" => "39"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Riveira-Munoz E, Chang Q, Bindels RJ, Devuyst O. Gitelman¿s syndrome: towards genotype-phenotype correlations? Pediatr Nephrol 2007;22:326-32. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17061123" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            39 => array:3 [
              "identificador" => "bib40"
              "etiqueta" => "40"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Yasujima M. Clinical significance of thiazide-sensitive Na-Cl cotransporter gene by mutational analysis. Rinsho Byori 2007;55:338-43. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17511264" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            40 => array:3 [
              "identificador" => "bib41"
              "etiqueta" => "41"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Calò LA, Davis PA, Palatini P, Semplicini A, Pessina AC. Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter¿s/Gitelman¿s syndromes and relevance for hypertension. J Hum Hypertens 2007;21:904-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17495949" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            41 => array:3 [
              "identificador" => "bib42"
              "etiqueta" => "42"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Scognamiglio R, Negut C, Calò LA. Aborted sudden cardiac death in two patients with Bartter¿s/Gitelman¿s syndromes. Clin Nephrol 2007;67:193-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17390745" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            42 => array:3 [
              "identificador" => "bib43"
              "etiqueta" => "43"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Takeuchi K. Hypertension and metabolic syndrome/lifestyle diseases. Rinsho Byori 2007;55:452-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17593691" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            43 => array:3 [
              "identificador" => "bib44"
              "etiqueta" => "44"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Ariceta G, Rodríguez-Soriano J. Inherited renal tubulopathies associated with metabolic alkalosis: effects on blood pressure. Semin Nephrol 2006;26:422-33. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17275579" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            44 => array:3 [
              "identificador" => "bib45"
              "etiqueta" => "45"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Rosenthal SM, Feldman BJ, Vargas GA, Gitelman SE. Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction. Pediatr Endocrinol Rev 2006;4 (Supl 1):66-70. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17261972" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            45 => array:3 [
              "identificador" => "bib46"
              "etiqueta" => "46"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Eto K, Onaka U, Tsuchihashi T, Hirano T, Nakayama M, Masutani K, et al. A case of Gitelman¿s syndrome with decreased angiotensin IIforming activity. Hypertens Res 2006;29:545-9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17044667" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            46 => array:3 [
              "identificador" => "bib47"
              "etiqueta" => "47"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Addolorato G, Ancarani F, Leggio L, Abenavoli L, De Lorenzi G, Montalto M, et al. Hypokalemic nephropathy in an adult patient with partial empty sella: a classic Bartter¿s syndrome, a Gitelman¿s syndrome or both? Panminerva Med 2006;48:137-42. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16953151" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
            47 => array:3 [
              "identificador" => "bib48"
              "etiqueta" => "48"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Morton A. Eplerenone in the treatment of Gitelman¿s syndrome. Intern Med J 2008;38:377. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18402570" target="_blank">[Pubmed]</a>"
                  "contribucion" => array:1 [
                    0 => null
                  ]
                  "host" => array:1 [
                    0 => null
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000002900000006/v0_201502091611/X2013251409033685/v0_201502091611/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35445"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Short Reviews"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002900000006/v0_201502091611/X2013251409033685/v0_201502091611/en/P-E-S-A439-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409033685?idApp=UINPBA000064"
]
Article information
ISSN: 20132514
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 16 6 22
2024 October 280 78 358
2024 September 278 40 318
2024 August 197 76 273
2024 July 174 48 222
2024 June 275 59 334
2024 May 224 57 281
2024 April 145 35 180
2024 March 169 41 210
2024 February 128 39 167
2024 January 154 38 192
2023 December 140 35 175
2023 November 151 46 197
2023 October 179 65 244
2023 September 139 42 181
2023 August 127 41 168
2023 July 153 49 202
2023 June 168 42 210
2023 May 164 53 217
2023 April 112 38 150
2023 March 120 22 142
2023 February 102 39 141
2023 January 134 27 161
2022 December 132 42 174
2022 November 187 50 237
2022 October 163 71 234
2022 September 140 62 202
2022 August 183 43 226
2022 July 203 72 275
2022 June 143 57 200
2022 May 154 38 192
2022 April 187 61 248
2022 March 142 54 196
2022 February 161 61 222
2022 January 165 52 217
2021 December 177 39 216
2021 November 161 60 221
2021 October 228 69 297
2021 September 154 47 201
2021 August 151 45 196
2021 July 131 41 172
2021 June 114 43 157
2021 May 130 39 169
2021 April 295 101 396
2021 March 192 19 211
2021 February 165 25 190
2021 January 89 21 110
2020 December 119 25 144
2020 November 109 19 128
2020 October 164 27 191
2020 September 93 14 107
2020 August 93 10 103
2020 July 89 13 102
2020 June 99 13 112
2020 May 119 17 136
2020 April 138 28 166
2020 March 149 15 164
2020 February 123 30 153
2020 January 184 25 209
2019 December 204 31 235
2019 November 222 21 243
2019 October 210 23 233
2019 September 234 29 263
2019 August 186 36 222
2019 July 203 31 234
2019 June 155 22 177
2019 May 208 26 234
2019 April 235 54 289
2019 March 154 40 194
2019 February 85 20 105
2019 January 84 37 121
2018 December 89 40 129
2018 November 155 20 175
2018 October 139 15 154
2018 September 95 16 111
2018 August 85 22 107
2018 July 63 19 82
2018 June 56 18 74
2018 May 64 13 77
2018 April 64 2 66
2018 March 58 8 66
2018 February 62 4 66
2018 January 78 6 84
2017 December 80 12 92
2017 November 44 3 47
2017 October 57 7 64
2017 September 70 12 82
2017 August 71 8 79
2017 July 67 11 78
2017 June 64 9 73
2017 May 84 23 107
2017 April 69 10 79
2017 March 66 8 74
2017 February 61 8 69
2017 January 43 8 51
2016 December 82 5 87
2016 November 98 12 110
2016 October 128 12 140
2016 September 161 5 166
2016 August 218 11 229
2016 July 169 8 177
2016 June 145 0 145
2016 May 154 0 154
2016 April 114 0 114
2016 March 115 0 115
2016 February 104 0 104
2016 January 125 0 125
2015 December 146 0 146
2015 November 127 0 127
2015 October 83 0 83
2015 September 76 0 76
2015 August 67 0 67
2015 July 74 0 74
2015 June 44 0 44
2015 May 41 0 41
2015 April 9 0 9
Show all

Follow this link to access the full text of the article

Idiomas
Nefrología (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?